| Title |
|
|
|
Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
BMC cancer. - London | |
| Publication |
|
|
|
London : 2018
| |
| ISSN |
|
|
|
1471-2407
| |
| Volume/pages |
|
|
|
18(2018), 11 p.
| |
| Article Reference |
|
|
|
761
| |
| ISI |
|
|
|
000439700100006
| |
| Pubmed ID |
|
|
|
30041599
| |
| Medium |
|
|
|
E-only publicatie
| |
| Full text (Publisher's DOI) |
|
|
| | |
| Full text (open access) |
|
|
| | |
|